ICU Medical (NASDAQ:ICUI) Releases FY 2022 Earnings Guidance
ICU Medical (NASDAQ:ICUI) Releases FY 2022 Earnings Guidance
ICU Medical (NASDAQ:ICUI – Get Rating) issued an update on its FY 2022 earnings guidance on Tuesday morning. The company provided earnings per share (EPS) guidance of $6.20-$6.80 for the period, compared to the consensus estimate of $9.17. The company issued revenue guidance of -.
ICU Medical(納斯達克代碼：ICUI-GET Rating)週二上午發佈了2022財年最新收益指引。該公司提供了6.20-6.80美元的每股收益指引，而普遍預期為9.17美元。該公司發佈了收入指引-。
ICU Medical Trading Down 0.9 %
ICU醫療降價0.9%
ICUI stock traded down $1.49 during mid-day trading on Tuesday, reaching $155.89. 2,098 shares of the stock traded hands, compared to its average volume of 233,627. The stock's fifty day moving average is $169.16 and its 200-day moving average is $193.86. The company has a current ratio of 2.45, a quick ratio of 1.25 and a debt-to-equity ratio of 0.78. The company has a market cap of $3.73 billion, a P/E ratio of 371.41 and a beta of 0.57. ICU Medical has a 52-week low of $155.34 and a 52-week high of $282.00.
週二午盤交易中，ICUI股價下跌1.49美元，至155.89美元。該股有2,098股易手，而其平均成交量為233,627股。該股的50日移動均線切入位為169.16美元，200日移動均線切入位為193.86美元。該公司的流動比率為2.45，速動比率為1.25，債務權益比率為0.78。該公司市值為37.3億美元，市盈率為371.41，貝塔係數為0.57.ICU Medical的52周低點為155.34美元，52周高位為282.00美元。
ICU Medical (NASDAQ:ICUI – Get Rating) last issued its quarterly earnings data on Monday, August 8th. The medical instruments supplier reported $1.37 earnings per share for the quarter, missing the consensus estimate of $1.68 by ($0.31). The business had revenue of $561.00 million for the quarter, compared to the consensus estimate of $569.30 million. ICU Medical had a net margin of 0.31% and a return on equity of 6.97%. ICU Medical's revenue was up 74.4% compared to the same quarter last year. During the same period in the previous year, the business posted $1.57 EPS. As a group, sell-side analysts expect that ICU Medical will post 5.23 earnings per share for the current year.
ICU Medical(納斯達克代碼：ICUI-GET Rating)最近一次發佈季度收益數據是在8月8日星期一。這家醫療器械供應商公佈本季度每股收益為1.37美元，低於普遍預期的1.68美元(0.31美元)。該業務本季度的收入為5.61億美元，而普遍預期為5.693億美元。ICU Medical的淨利潤率為0.31%，股本回報率為6.97%。與去年同期相比，ICU Medical的收入增長了74.4%。去年同期，該業務公佈的每股收益為1.57美元。賣方分析師預計，作為一個整體，ICU Medical本年度每股收益將達到5.23美元。
Analysts Set New Price Targets
分析師設定新的價格目標
Institutional Inflows and Outflows
機構資金流入和流出
A number of institutional investors have recently made changes to their positions in the business. Vanguard Group Inc. increased its position in ICU Medical by 8.8% in the first quarter. Vanguard Group Inc. now owns 2,122,104 shares of the medical instruments supplier's stock worth $472,466,000 after purchasing an additional 171,851 shares during the period. Wellington Management Group LLP lifted its stake in ICU Medical by 71.6% in the 1st quarter. Wellington Management Group LLP now owns 1,516,089 shares of the medical instruments supplier's stock valued at $337,542,000 after acquiring an additional 632,609 shares in the last quarter. Dimensional Fund Advisors LP raised its stake in shares of ICU Medical by 2.0% during the 1st quarter. Dimensional Fund Advisors LP now owns 342,453 shares of the medical instruments supplier's stock worth $76,248,000 after purchasing an additional 6,562 shares in the last quarter. Eaton Vance Management raised its stake in ICU Medical by 45.4% in the 1st quarter. Eaton Vance Management now owns 265,343 shares of the medical instruments supplier's stock valued at $59,077,000 after acquiring an additional 82,861 shares during the period. Finally, Northern Trust Corp raised its stake in ICU Medical by 5.7% in the 2nd quarter. Northern Trust Corp now owns 240,230 shares of the medical instruments supplier's stock valued at $39,491,000 after acquiring an additional 12,974 shares during the period. 90.20% of the stock is owned by institutional investors.
一些機構投資者最近改變了他們在該業務中的頭寸。先鋒集團(Vanguard Group Inc.)在第一季度將其在ICU Medical的頭寸增加了8.8%。先鋒集團目前持有這家醫療器械供應商2,122,104股股票，價值472,466,000美元，在此期間又購買了171,851股。惠靈頓管理集團LLP在第一季度增持了71.6%的ICU Medical股份。惠靈頓管理集團(Wellington Management Group LLP)現在擁有這家醫療器械供應商1,516,089股股票，價值337,542,000美元，上個季度又收購了632,609股。Dimension Fund Advisors LP在第一季度將其在ICU Medical的股份增加了2.0%。Dimension Fund Advisors LP在上個季度額外購買了6,562股後，現在擁有這家醫療器械供應商價值76,248,000美元的股票342,453股。伊頓·萬斯管理公司在第一季度增持了45.4%的ICU醫療股份。伊頓·萬斯管理公司在此期間額外收購了82,861股，現在擁有這家醫療器械供應商265,343股股票，價值59,077,000美元。最後，北方信託公司在第二季度將其在ICU Medical的持股比例提高了5.7%。北方信託公司現在擁有240,230股這家醫療器械供應商的股票，價值39,491,000美元，在此期間又購買了12,974股。90.20%的股票由機構投資者持有。
About ICU Medical
關於ICU醫療
(Get Rating)
(獲取評級)
ICU Medical, Inc, together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy and critical care applications worldwide. The company's infusion therapy products include needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; SwabCap and SwabTip disinfecting caps; Tego hemodialysis connectors; ClearGuard HD, an antimicrobial barrier cap for hemodialysis catheters; and ChemoClave and ChemoLock closed system transfer devices, as well as Diana hazardous drug compounding system for the preparation of hazardous drugs.
ICU醫療公司及其子公司在全球範圍內開發、製造和銷售用於輸液治療和危重護理應用的醫療設備。該公司的輸液治療產品包括MicroClave、MicroClave Clear和NanoClave品牌的無針產品；中子導管通暢設備；SwabCap和SwabTip消毒帽；Tego血液透析連接器；ClearGuard HD，血液透析導管的抗菌屏障帽；ChemoClave和ChemoLock封閉式系統傳輸設備，以及用於製備危險藥物的Diana危險藥物複合系統。
Recommended Stories
推薦故事
- Get a free copy of the StockNews.com research report on ICU Medical (ICUI)
- Broadcom Bounces From Institutional Bottom
- Affirm is the Underdog Starring in a Spaghetti Western
- Is Autozone A Buy Before Earnings Are Released?
- Is There Value in Verizon Shares at These Levels?
- MarketBeat Podcast: Stock Market, Bad News is Good News
- 免費獲取StockNews.com關於ICU醫學的研究報告(ICUI)
- 博通從機構底部反彈
- 阿奎姆是意大利西部片中的失敗者
- AutoZone是在收益發布之前買入的嗎？
- 在這些水平上，Verizon的股價有價值嗎？
- 市場Beat播客：股市，壞消息就是好消息
Receive News & Ratings for ICU Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ICU Medical and related companies with MarketBeat.com's FREE daily email newsletter.
接受ICU醫學日報的新聞和評級-在下面輸入您的電子郵件地址，通過MarketBeat.com的免費每日電子郵件時事通訊接收對ICU醫療及相關公司的最新新聞和分析師評級的每日簡要摘要。